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ABSTRACT
Bacillus Calmette Guerin (BCG) vaccine, which is administered to all newborns in some regions, 
could lead to serious complication ranging from local disease (known as BCGitis) to disseminated 
disease (BCGosis) in a group of patients with primary immunodefi ciency diseases. We are report-
ing here a 3.5 year-old girl with a history of prolonged BCGitis, which developed to disseminated 
disease without any other special features. Immunological studies with nitro-blue tetrazolium test 
confi rmed the diagnosis of chronic granulomatous disease in this patient. Chronic granulomatous 
disease should be considered in the list of differential diagnosis in all children with BCGosis, even in 
the absence of any other manifestations related to immunodefi ciency.
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INTRODUCTION 
Chronic granulomatous disease (CGD) is 
a congenital hereditary disorder of the im-
mune system, characterized by absence of 
superoxide and hydrogen peroxide produc-
tion in phagocytes.1-3 CGD is inherited as an 
x-linked recessive trait or as an autosomal 
recessive.3,4 
The patients with CGD may present var-
iable manifestations, but severe infections 
in infancy are the most common presenting 
features.5-7 As the disease affects macrophag-
es and neutrophils, CGD leads to recurrent 
symptomatic cutaneous, subcutaneous and 
bone infections as well as abscess formation 
and lymphadenitis. Lower respiratory tract 
infections, especially caused by microor-
ganisms that form abscesses and pneuma-
toceles, are also common in the course of 
disease.7,8
Here, a unique feature of the disease is 
described in a child primarily infected with 
Bacillus Calmette Guerin (disseminated 
BCG) after routine vaccination for BCG in a 
national vaccination program.
CASE REPORT
A 3.5 year-old girl was referred to the Chil-
dren’s Medical Center in Tehran, Iran with 
complaint of an overgrowing axillary mass 
protruding to the anterior chest wall. The 
mass was primarily detected as a nodule 
in early life; as the parents could recall, it 
originated at the time of early vaccination 
at neonatal period. However, the nodule has 
recently begun to grow in size throughout 
the last four months. The parents were also 
apprehensive due to productive coughs, fe-
ver, loss of appetite and night sweating of 
their child, which had gradually begun at 
the time of the axillary mass growth.
Although there was a negative history of 
previous hospital admission or any appar-
ent serious illness, the patient had several 
visits to the pediatrician during the first two 
months of life due to the described nodule 
and the parents had been reassured many 
times about the nature of the nodule which 
was described by doctors as a reaction to 
BCG vaccine sometimes seen in newborns 
after vaccination. 
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At the time of admission, the patient was ill, but not 
toxic; she had low grade fever. At pulmonary auscul-
tation of the upper and middle lobe of the right lung 
breathing sounds were increased and coarse. A firm ill-
defined tender mass was palpated in the right axillary 
region, which was extended to the right anterior chest 
wall about the midclavicular line of the third intercos-
tals space (Figure 1).
Figure 2: Chest x-ray of the patient showing a homogenous 
density with an alveolar-filling pattern in the right upper and 
middle lobes.
Figure 3: Chest CT scan of the patient showing alveolar opacity 
with air bronchogram in right upper and middle lobes.
Laboratory tests and imaging studies were per-
formed. The primary laboratory findings were as 
follows: white blood cell count: 17,800/mm3 (neu-
trophils: 69% and lymphocytes: 31%), hemo-
globin concentration: 10.7 g/dL, platelet count: 
449,000/mm3, and erythrocyte sedimentation rate (ESR): 
118 mm/h. The patient had a 4+ positive C-reactive pro-
tein (CRP). Chest roentgenogram (CXR) revealed a ho-
mogenous density with an alveolar-filling pattern in the 
right upper and middle lobes with a small lucency within 
the upper lobe density, which suggested a cavity forming 
pneumonia (Figure 2).
Considering the history of chronic cough, staining 
of sputum for acid-fast bacilli (AFB) was performed 
for the patient. Meanwhile, spiral computed tomog-
raphy (CT) scanning of the chest with intravenous 
contrast enhancement was done for further evalua-
tion of the chest wall mass and also for prompt diag-
nosis of findings on the CXR. The chest CT scan re-
ported alveolar opacity with air bronchogram in right 
upper and middle lobes and also left lingual lobe sug-
gestive of pneumonia and mediastinal lymphadenopathy 
(Figure 3), all together compatible with primary tubercu-
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losis infection. There was also a cystic mass (continuation 
of the axillary mass, which was 55 x 24 mm in size) with 
rim enhancement anterior to the sternum that could be 
an abscess. 
These findings raised the question about the compe-
tency of the immune system of the child. Hence, a series 
of the immune system assessment studies were done. 
Figure 1: Scar of the lesion in the right axillary region, 
extended to the right anterior chest wall.
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Serum IgG level was 2,136 mg/dL (normal: 441–1,135 
mg/dL). Serum IgM was in high normal range (332 mg/
dL) and IgA was within normal range (243 mg/dL). HIV 
ELISA test was negative. However, nitroblue-tetrazolium 
(NBT) slide test, which is performed to assess the phago-
cytic cell function, revealed a defect in phagocytic cell 
function (NBT: 0%), which was compatible with diagno-
sis of CGD.
The chest wall abscess underwent needle aspiration 
and sent for acid fast stain and routine KOH smear. Stain-
ing of the aspirated fluid disclosed Aspergillus fumigates. 
Besides, all three specimens of gastric lavage turned out 
positive for AFB; therefore conventional anti-TB regi-
men and anti-fungal therapies were administered for the 
patient. The abscess was once again aspirated and got 
smaller.
As the diagnosis of CGD was made, the patient re-
ceived interferon-gamma (IFN-γ 50 µg/sc/3 times in 
week), streptomycin, isoniazid, ethambutol, rifampin, 
and amphotericin B.
Two weeks after anti-TB and anti-fungal therapy, the 
child’s appetite had improved and the respiratory com-
plaints declined. The mass size became smaller and the 
patient was discharged in good clinical condition.
DISCUSSION
In this case study, an atypical feature of CGD, a child pri-
marily presented with BCG-induced lymphadenitis which 
progressed to BCGosis after about three years. CGD is a 
rare but well-known congenital disorder of the immune 
system, with an estimated 10-year cumulative incidence 
rate of 2.25 per 100,000 individuals in our country.9 
The majority of CGD patients suffer from recurrent 
infection caused by Staphylococcus species, Gram-negative 
bacilli (like Escherichia coli or Klebsiella), and also sapro-
phytic fungi, particularly Aspergillus species.5-7 Here, the 
patient presented with a rare but important complication 
of BCG vaccine, lymphadenitis. Overall, BCG vaccine is 
safe, but it may lead to a number of complications such as 
localized ulceration regional lymphadenopathies, which 
occur after inoculation and is managed by just waiting 
and watching unless it becomes fluctuated or shows an 
overgrowth in size.10 It is believed that some primary im-
munodeficiency diseases, including severe combined im-
munodeficiency, CGD and Mendelian susceptibility to 
mycobacterial diseases, are prone to severe mycobacterial 
disease following BCG vaccination.11-13
Surely, one of the most important aspects in optimal 
management of chronic diseases, like CGD, is the time 
of diagnosis. Early diagnosis would lead to a more ag-
gressive management at the initial stages of the disease 
which could in turn, decrease complications. In Iran, the 
diagnostic test for CGD is based on the results of either 
NBT or dihydrorhodamine (DHR) 123 test. The response 
of NBT test depends on the competence of normal neu-
trophils to reduce the colorless NBT dye to blue forma-
zen during phagocytosis. Conclusively, as a result of the 
absence of minimal oxidative metabolism in CGD, a 
negative test is diagnostic. Although this exact diagnosis 
is achieved by the test mentioned above, a strong clini-
cal suspicion is essential. Beyond any doubt, in such an 
atypical case, as presented here, understanding rare clini-
cal manifestations could prompt early request of diagnos-
tic tests like NBT. It is worthy to declare that although 
x-linked CGD is the most common types of disease 
(about 60%) in the western countries, autosomal reces-
sive form of the disease seems to be more common in 
Middle East countries due to high rate of consanguine-
ous marriages.14 Autosomal recessive inheritance was also 
expected in our case, as the patient was a girl. 
Other interesting features of this case which indeed 
had an atypical presentation, is the patient’s age at the 
time of disease presentation. CGD is a hereditary disease, 
characterized by severe infections of various body organs 
mostly present in the first year of life.6,7 In this case the 
only disease manifestation was an axillary nodule which 
remained unchanged during a 3-year period. Hence, this 
case could be considered as a late-onset form of the dis-
ease.
Finally, it seems that the clinical significance of this 
case report is the suggestion of persistent axillary lym-
phadenitis as a sentinel sign for immune disorders, par-
ticularly CGD. Surely, prompt diagnosis of such diseases 
would lead to a better clinical outcome, as for this case. 
Early administration of gamma interferon and itracona-
zole prophylaxis, for example, might prevent dissemi-
nated BCGosis and secondary fungal infection of the 
inflamed lymph node. Since the routine national vacci-
nation program in Iran includes BCG vaccine, CGD as 
well as other primary immunodeficiency diseases, such 
as severe combined immunodeficiency and Mendelian 
susceptibility to mycobacterial diseases should be consid-
ered in the patients with disseminated disease after BCG 
inoculation.
REFERENCES
1. Winkelstein JA, Marino MC, Johnston RB Jr et al. Chronic 
granulomatous disease. Report on a national registry of 368 
patients. Medicine (Baltimore) 2000; 79:155-69.
2. Martín Mateos MA, Alvaro M, Giner MT et al. Chronic 
granulomatous disease: six new cases. Allergol Immuno-
pathol. (Madr) 1998; 26:241-9.
3. Movahedi M, Aghamohammadi A, Rezaei N et al. Chronic 
granulomatous disease: a clinical survey of 41 patients from 
the Iranian primary immunodeficiency registry. Int Arch 
Allergy Immunol. 2004; 134:253-9.
4. van den Berg JM, van Koppen E, Ahlin A et al. Chronic 
granulomatous disease: the European experience. PLoS 
One 2009; 4:e5234.
Movahedi, Norouzi, Mamishi et al.
86
5. Cohen MS, Isturiz RE, Malech HL et al. Fungal infection 
in chronic granulomatous disease. The importance of the 
phagocyte in defense against fungi. Am J Med. 1981; 71:59-
66.
6. Johnston RB Jr. Clinical aspects of chronic granulomatous 
disease. Curr Opin Hematol. 2001; 8:17-22.
7. Martire B, Rondelli R, Soresina A et al. IPINET. Clinical fea-
tures, long-term follow-up and outcome of a large cohort 
of patients with Chronic Granulomatous Disease: an Italian 
multicenter study. Clin Immunol. 2008; 126:155-64.
8. Rosenzweig SD. Chronic granulomatous disease: complica-
tions and management. Expert Rev Clin Immunol. 2009; 
5:45-53.
9. Rezaei N, Aghamohammadi A, Moin M et al. Frequency and 
clinical manifestations of patients with primary immuno-
deficiency disorders in Iran: update from the Iranian Pri-
mary Immunodeficiency Registry. J Clin Immunol. 2006; 
26:519-32.
10. Grange JM. Complications of bacille Calmette-Guérin 
(BCG) vaccination and immunotherapy and their manage-
ment. Commun Dis Public Health 1998; 1:84-8.
11. Rezai MS, Khotaei G, Mamishi S et al. Disseminated Bacil-
lus Calmette-Guerin infection after BCG vaccination. J Trop 
Pediatr. 2008; 54:413-6.
12. Sadeghi-Shabestari M, Rezaei N. Disseminated bacille Cal-
mette-Guérin in Iranian children with severe combined im-
munodefi ciency. Int J Infect Dis. 2009; 13:e420-3.
13. Reichenbach J, Rosenzweig S, Doffi nger R et al. Mycobacterial 
diseases in primary immunodefi ciencies. Curr Opin Allergy 
Clin Immunol. 2001; 1:503-11.
14. Rezaei N, Pourpak Z, Aghamohammadi A et al. Consanguin-
ity in primary immunodefi ciency disorders; the report from 
Iranian Primary Immunodefi ciency Registry. Am J Reprod 
Immunol. 2006; 56:145-51.
